Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia

• Status: Unknown status
• Trial end date: 2011-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to establish the long-term safety and efficacy of Biogeneric Epoetin, the attainability of therapeutic target for anaemia management, and the impact of Epoetin treatment on long-term health outcome and its cost effectiveness.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ministry of Health, Malaysia
• Treatments: Epoetin Alfa

Criteria

Inclusion Criteria:

• Patient who has Chronic Kidney Disease with anaemia for which Epoetin treatment is indicated.

• Patient without known hypersensitivity to the mammalian cell-derived product or human albumin products.